Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36 NMQ Palacpac, E Ntege, A Yeka, B Balikagala, N Suzuki, H Shirai, ... PLoS One 8 (5), e64073, 2013 | 92 | 2013 |
Continuing Intense Malaria Transmission in Northern Uganda C Proietti, DD Pettinato, BN Kanoi, E Ntege, A Crisanti, EM Riley, ... The American Journal of Tropical Medicine and Hygiene 84 (5), 830-837, 2011 | 65 | 2011 |
Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions RJ Longley, MT White, E Takashima, M Morita, BN Kanoi, CSNLW Suen, ... PLOS Neglected Tropical Diseases 11 (9), e0005888, 2017 | 59 | 2017 |
Influence of infection on malaria‐specific antibody dynamics in a cohort exposed to intense malaria transmission in northern U ganda C Proietti, F Verra, MT Bretscher, W Stone, BN Kanoi, B Balikagala, ... Parasite immunology 35 (5-6), 164-173, 2013 | 53 | 2013 |
Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda BN Kanoi, E Takashima, M Morita, MT White, NMQ Palacpac, EH Ntege, ... Vaccive, 2017 | 45 | 2017 |
PV1, a novel Plasmodium falciparum merozoite dense granule protein, interacts with exported protein in infected erythrocytes M Morita, H Nagaoka, EH Ntege, BN Kanoi, D Ito, T Nakata, JW Lee, ... Scientific reports 8 (1), 3696, 2018 | 34 | 2018 |
Leveraging the wheat germ cell-free protein synthesis system to accelerate malaria vaccine development BN Kanoi, H Nagaoka, M Morita, T Tsuboi, E Takashima Parasitology International 80, 102224, 2021 | 27 | 2021 |
New concepts in vaccine development in malaria BN Kanoi, TG Egwang Current Opinion in Infectious Diseases 20 (3), 311-316, 2007 | 26 | 2007 |
Identification of Novel Malaria Transmission-Blocking Vaccine Candidates E Takashima, M Tachibana, M Morita, H Nagaoka, BN Kanoi, T Tsuboi Frontiers in Cellular and Infection Microbiology, 1224, 2021 | 22 | 2021 |
Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda M Yagi, NMQ Palacpac, K Ito, Y Oishi, S Itagaki, B Balikagala, EH Ntege, ... Scientific Reports 6 (1), 34363, 2016 | 22 | 2016 |
Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population BN Kanoi, H Nagaoka, MT White, M Morita, NMQ Palacpac, EH Ntege, ... Frontiers in Immunology 11, 893, 2020 | 21 | 2020 |
Antibodies against a short region of PfRipr inhibit Plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A H Nagaoka, BN Kanoi, EH Ntege, M Aoki, A Fukushima, T Tsuboi, ... Scientific Reports 10 (1), 6573, 2020 | 19 | 2020 |
Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains BN Kanoi, H Nagaoka, M Morita, MT White, NMQ Palacpac, EH Ntege, ... Vaccine, 2018 | 18 | 2018 |
PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47) H Nagaoka, C Sasaoka, T Yuguchi, BN Kanoi, D Ito, M Morita, ... Scientific Reports 9 (1), 5923, 2019 | 17 | 2019 |
Malaria transmission-blocking vaccines: wheat germ cell-free technology can accelerate vaccine development K Miura, M Tachibana, E Takashima, M Morita, BN Kanoi, H Nagaoka, ... Expert review of vaccines 18 (10), 1017-1027, 2019 | 14 | 2019 |
Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission Hirokazu Sakamoto, Satoru Takeo, Eizo Takashima, Kazutoyo Miura, Bernard N ... Parasitology International, 2017 | 13* | 2017 |
The N-Terminal Region of Plasmodium falciparum MSP10 is a target of protective antibodies in Malaria and is important for PfGAMA/PfMSP10 interaction H Nagaoka, BN Kanoi, K Jinoka, M Morita, TU Arumugam, NMQ Palacpac, ... Frontiers in immunology 10, 2669, 2019 | 12 | 2019 |
Hematological and biochemical data obtained in rural Northern Uganda NMQ Palacpac, E Ntege, B Balikagala, A Yeka, H Shirai, N Suzuki, ... International Journal of Environmental Research and Public Health 11 (5 …, 2014 | 10 | 2014 |
COVID-19 vaccinology landscape in Africa S Baptista, S Naidoo, S Suliman, E Nepolo, BN Kanoi, J Gitaka, ... Frontiers in Immunology, 7424, 2022 | 6 | 2022 |
Plasmodium yoelii erythrocyte binding like protein interacts with basigin, an erythrocyte surface protein T Yuguchi, BN Kanoi, H Nagaoka, T Miura, D Ito, H Takeda, T Tsuboi, ... Frontiers in cellular and infection microbiology 11, 296, 2021 | 6 | 2021 |